| Trial ID: | L5187 |
| Source ID: | NCT04930679
|
| Associated Drug: |
Andiabet
|
| Title: |
Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Andiabet
|
| Outcome Measures: |
Primary: Adverse events, 2 AEs recorded, there were changes in biochemical indices. However, these AEs are considered mild and unrelated to the investigated product., 28 days|Fasting blood glucose, Group II is reported to have lower blood glucose compared to group I. However, the difference is efficacy is not clear between 2 groups, 28 days |
|
| Sponsor/Collaborators: |
Sponsor: Centre of Clinical Pharmacology, Hanoi Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-11-24
|
| Completion Date: |
2019-02-22
|
| Results First Posted: |
|
| Last Update Posted: |
2021-06-18
|
| Locations: |
Centre of Clinical Pharmacology, Hanoi Medical University, Hanoi, Vietnam
|
| URL: |
https://clinicaltrials.gov/show/NCT04930679
|
